|Controller - EvoFem Biosciences
Ivy Zhang is Controller of Evofem Biosciences, where she is responsible for managing financial risk, guiding decision-making, and leading the SEC/SOX compliance, accounting and audit functions. Ivy joined Evofem shortly after the Company emerged from a complicated reverse merger transaction in 2018. Ivy has since exceeded all expectations, elevating Evofem’s already strong reporting processes and ensuring precision across all accounting procedures and internal control systems in preparation for the launch of a new, first-in-class, hormone-free contraceptive option for millions of women in the United States.
Prior to her role as Controller, Ivy led Evofem’s SEC Reporting and SOX Compliance function, where she maintained the Company’s internal control documentation and led consultants in successfully implementing numerous process improvements across the organization. Previously, she served in senior management roles at SeaSpine Holdings Corporation, where she was tasked with leading the Company’s external reporting, technical accounting and tax functions. From 2008 to 2015, Ivy provided her expertise to Ernst & Young as an Assurance Manager, navigating an IPO, corporate audit and numerous client filings.
Ivy’s contributions have spanned the pharmaceutical, medical device, energy trading, architecture and private equity industries. She holds a Master’s in Assurance from Virginia Tech and received a Master’s in Economics from the University of Victoria. Ivy is a trusted leader who is dedicated to advancing the Company’s mission of addressing the unmet sexual and reproductive health needs of women. She is also the loving mother of two children and incredibly adept at balancing the demands of both roles.